ArticleCancer immunology, immunotherapy : CII2011

A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4⁺ and CD8⁺ T-cell as well as B-cell responses.

Frank Neumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.